Apollo Hospitals Enterprise Ltd share price gained after posting strong Q4 results for FY25. The company crossed a consolidated revenue of ₹20,000 crore and declared a final dividend of ₹10 per share. With record performance, a robust outlook for Healthcare Services, and expansion in Bengaluru, Apollo Hospitals continues to make headlines across the healthcare and stock market landscape.
Apollo Hospitals Enterprise Ltd witnessed a 1.30% increase in its share price on June 2, following the release of its March quarter results. The results, announced after market hours on Friday, highlighted a strong operational and financial performance for the company.
Key consolidated year-on-year highlights include:
Read More: Best Pharma Stocks in June 2025!
Apollo Hospitals reported consolidated revenue for FY25 exceeding ₹20,000 crore, marking a significant achievement. Within this, Healthcare Services revenue surpassed ₹10,000 crore, reflecting strong demand, enhanced capacities, and efficient service delivery across the group’s facilities.
This performance cements Apollo’s standing among India’s leading healthcare providers and underlines its nationwide operational footprint.
The board of Apollo Hospitals has recommended a final dividend of ₹10 per equity share with a face value of ₹5 for the financial year 2024-25. This follows the interim dividend of ₹9 per share that was paid on February 28.
Key dividend dates:
Apollo Hospitals has revealed plans for a major expansion in Bengaluru’s Sarjapur micro-market. The group will add 700 beds in 2 phases, significantly increasing its capacity and strengthening its presence in the city’s South-Eastern region.
This move targets a large addressable market and aligns with Apollo’s strategy to deepen its roots in high-growth urban healthcare corridors.
Dr Prathap C Reddy, Chairman of Apollo Hospitals, stated, “At Apollo, our mission has always gone beyond treating illness. It is about enabling every individual to live a healthier, happier life. FY25 was a defining year. With revenues crossing ₹20,000 crore and Healthcare Services surpassing ₹11,000 crore, we are humbled by the trust placed in us across India and beyond.”
His statement reinforces the company’s people-first philosophy and strategic clarity in expanding operations while keeping patient outcomes at the centre.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 2, 2025, 3:27 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates